サマリー

中東とアフリカのラジオイムノアッセイ市場は、2023年から2030年の予測期間に2.8%の大幅なCAGRを記録すると予測されています。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年であり、予測期間は2023年から2030年です。
市場セグメンテーションを行います：
中東およびアフリカのラジオイムノアッセイ市場、製品タイプ別（ラジオイムノアッセイ試薬およびキット、ラジオイムノアッセイアナライザー）、アプリケーション（科学研究および臨床診断）、エンドユーザー（病院、臨床診断研究所、学術研究機関、製薬およびバイオ医薬品産業、受託研究機関、その他）、流通チャネル（直接入札、オンライン販売、第三者流通、その他）、国（中国、日本、インド、韓国、オーストラリア、インドネシア、フィリピン、タイ、マレーシア、シンガポール、中東・アフリカのその他） 産業動向と2030年までの予測

中東・アフリカのラジオイムノアッセイ市場の成長に寄与する主な要因として、以下のものが挙げられます：
- 高スループットおよび自動化された手順による、エラーのない正確な結果に対する需要の増加
- 技術的進歩の高まり
- 市場関係者の戦略的な取り組み
- 医学における研究開発の意義が高まる

市場のプレーヤー：

中東・アフリカのラジオイムノアッセイ市場の主要な市場関係者は以下の通りです：

- パーキンエルマー社（PerkinElmer Inc.
- メルクKGaA
- EUROIMMUN Medizinische Labordiagnostika AG
- ベックマン・コールター社（Beckman Coulter, Inc.
- ハイデックスOy.

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 65
1.1 OBJECTIVES OF THE STUDY 65
1.2 MARKET DEFINITION 65
1.3 OVERVIEW OF MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET 65
1.4 LIMITATIONS 67
1.5 MARKETS COVERED 67
2 MARKET SEGMENTATION 71
2.1 MARKETS COVERED 71
2.2 GEOGRAPHICAL SCOPE 72
2.3 YEARS CONSIDERED FOR THE STUDY 73
2.4 CURRENCY AND PRICING 73
2.5 DBMR TRIPOD DATA VALIDATION MODEL 74
2.6 MULTIVARIATE MODELLING 77
2.7 PRODUCT TYPE LIFELINE CURVE 77
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 78
2.9 DBMR MARKET POSITION GRID 79
2.10 MARKET TESTING TYPE COVERAGE GRID 81
2.11 VENDOR SHARE ANALYSIS 82
2.12 SECONDARY SOURCES 83
2.13 ASSUMPTIONS 83
3 EXECUTIVE SUMMARY 84
4 PREMIUM INSIGHTS 87
4.1 PESTEL ANALYSIS 88
4.2 PORTYER’S FIVE FORCES 89
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 90
5 INDUSTRY INSIGHTS: 91
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 92
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 92
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 93
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 94
7 MARKET OVERVIEW 95
7.1 DRIVERS 97
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 97
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 97
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 98
7.2 RESTRAINTS 98
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 98
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 99
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 99
7.3 OPPORTUNITIES 100
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 100
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 100
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 101
7.4 CHALLENGES 103
7.4.1 LACK OF SKILLED PROFESSIONALS 103
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 103
8 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 104
8.1 OVERVIEW 105
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 108
8.2.1 KITS 109
8.2.2 BUFFER 109
8.2.2.1 SOLUTION 109
8.2.2.2 POWDER 109
8.2.3 STANDARD CONCENTRATES 110
8.2.4 PRECIPITATING REAGENTS 110
8.2.5 RADIOISOTOPES 110
8.2.5.1 BETA EMITTERS 110
8.2.5.1.1 TRITIUM 110
8.2.5.1.2 CARBON-14 111
8.2.5.2 GAMMA EMITTERS 111
8.2.5.2.1 IODINE-125 111
8.2.5.2.2 CHROMIUM-51 111
8.2.5.2.3 COBALT-57 111
8.2.6 ANTIBODY/ANTISERUM 112
8.2.6.1 POLYCLONAL 112
8.2.6.2 MONOCLONAL 112
8.2.7 OTHERS 112
8.3 RADIOIMMUNOASSAY ANALYZER 113
9 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: BY APPLICATION 114
9.1 OVERVIEW 115
9.2 SCIENTIFIC RESEARCH 118
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 119
9.2.2 RADIOIMMUNOASSAY ANALYZER 119
9.3 CLINICAL DIAGNOSIS 119
9.3.1 INFECTIOUS DISEASE TESTING 120
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 120
9.3.1.2 RADIOIMMUNOASSAY ANALYZER 120
9.3.2 ALLERGY TESTING 121
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.2.2 RADIOIMMUNOASSAY ANALYZER 121
9.3.3 ONCOLOGY TESTING 121
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 121
9.3.3.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.4 ENDOCRINE TESTING 122
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
9.3.4.2 RADIOIMMUNOASSAY ANALYZER 122
9.3.5 TOXICOLOGY TESTING 123
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
9.3.5.2 RADIOIMMUNOASSAY ANALYZER 123
9.3.6 AUTOIMMUNE DISEASE TESTING 123
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
9.3.6.2 RADIOIMMUNOASSAY ANALYZER 124
9.3.7 OTHER DISEASE TESTING 124
10 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY END USER 125
10.1 OVERVIEW 126
10.2 HOSPITALS 129
10.3 CLINICAL DIAGNOSTIC LABORATORIES 129
10.4 ACADEMIC AND RESEARCH INSTITUTES 130
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 131
10.6 CONTRACT RESEARCH ORGANISATIONS 131
10.7 OTHERS 132
11 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 133
11.1 OVERVIEW 134
11.2 DIRECT TENDER 137
11.3 ONLINE SALES 138
11.4 THIRD PARTY DISTRIBUTIONS 139
11.5 OTHERS 140
12 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY REGION 141
12.1 MIDDLE EAST AND AFRICA 142
12.1.1 SOUTH AFRICA 154
12.1.2 SAUDI ARABIA 161
12.1.3 UAE 168
12.1.4 EGYPT 176
12.1.5 ISRAEL 184
12.1.6 REST OF MIDDLE EAST AND AFRICA 192
13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 193
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 193
14 SWOT ANALYSIS 194
15 COMPANY PROFILE 195
15.1 PERKINELMER INC. 195
15.1.1 COMPANY SNAPSHOT 195
15.1.2 REVENUE ANALYSIS 195
15.1.3 COMPANY SHARE ANALYSIS 196
15.1.4 PRODUCT PORTFOLIO 196
15.1.4 RECENT DEVELOPMENT 197
15.2 MERCK KGAA 198
15.2.1 COMPANY SNAPSHOT 198
15.2.2 REVENUE ANALYSIS 198
15.2.3 COMPANY SHARE ANALYSIS 199
15.2.4 PRODUCT PORTFOLIO 199
15.2.5 RECENT DEVELOPMENTS 199
15.3 BECKMAN COULTER, INC. 201
15.3.1 COMPANY SNAPSHOT 201
15.3.2 COMPANY SHARE ANALYSIS 201
15.3.3 PRODUCT PORTFOLIO 201
15.3.4 RECENT DEVELOPMENT 202
15.4 ABCAM PLC 203
15.4.1 COMPANY SNAPSHOT 203
15.4.2 REVENUE ANALYSIS 203
15.4.3 COMPANY SHARE ANALYSIS 204
15.4.4 PRODUCT PORTFOLIO 204
15.4.5 RECENT DEVELOPMENT 204
15.5 TECAN TRADING AG 205
15.5.1 COMPANY SNAPSHOT 205
15.5.2 REVENUE ANALYSIS 205
15.5.3 COMPANY SHARE ANALYSIS 206
15.5.4 PRODUCT PORTFOLIO 206
15.5.5 RECENT DEVELOPMENT 207
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 208
15.6.1 COMPANY SNAPSHOT 208
15.6.2 PRODUCT PORTFOLIO 208
15.6.3 RECENT DEVELOPMENTS 208
15.7 DEMEDITEC DIAGNOSTICS GMBH 209
15.7.1 COMPANY SNAPSHOT 209
15.7.2 PRODUCT PORTFOLIO 209
15.7.3 RECENT DEVELOPMENTS 210
15.8 DIASOURCE 211
15.8.1 COMPANY SNAPSHOT 211
15.8.2 PRODUCT PORTFOLIO 211
15.8.3 RECENT DEVELOPMENT 211
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 212
15.9.1 COMPANY SNAPSHOT 212
15.9.2 PRODUCT PORTFOLIO 212
15.9.3 RECENT DEVELOPMENTS 212
15.10 HIDEX OY 214
15.10.1 COMPANY SNAPSHOT 214
15.10.2 PRODUCT PORTFOLIO 214
15.10.3 RECENT DEVELOPMENTS 214
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 215
15.11.1 COMPANY SNAPSHOT 215
15.11.2 PRODUCT PORTFOLIO 215
15.11.3 RECENT DEVELOPMENT 217
15.12 INSTITUTE OF ISOTOPES 218
15.12.1 COMPANY SNAPSHOT 218
15.12.2 PRODUCT PORTFOLIO 218
15.12.3 RECENT DEVELOPMENTS 219
15.13 KAMIYA BIOMEDICAL COMPANY 220
15.13.1 COMPANY SNAPSHOT 220
15.13.2 PRODUCT PORTFOLIO 220
15.13.3 RECENT DEVELOPMENTS 220
15.14 MP BIOMEDICALS 221
15.14.1 COMPANY SNAPSHOT 221
15.14.2 PRODUCT PORTFOLIO 221
15.14.3 RECENT DEVELOPMENTS 222
15.15 MYBIOSOURCE.COM. 223
15.15.1 COMPANY SNAPSHOT 223
15.15.2 PRODUCT PORTFOLIO 223
15.15.3 RECENT DEVELOPMENT 223
16 QUESTIONNAIRE 224
17 RELATED REPORTS 227

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 51
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 56
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 57
TABLE 4 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
TABLE 5 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 66
TABLE 6 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 7 MIDDLE EAST & AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 8 MIDDLE EAST & AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
TABLE 9 MIDDLE EAST & AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
TABLE 10 MIDDLE EAST & AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 11 MIDDLE EAST & AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 12 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 13 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 75
TABLE 14 MIDDLE EAST & AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 15 MIDDLE EAST & AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 76
TABLE 16 MIDDLE EAST & AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 17 MIDDLE EAST & AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 78
TABLE 18 MIDDLE EAST & AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 78
TABLE 19 MIDDLE EAST & AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 79
TABLE 20 MIDDLE EAST & AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 79
TABLE 21 MIDDLE EAST & AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 80
TABLE 22 MIDDLE EAST & AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 81
TABLE 23 MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 81
TABLE 24 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 86
TABLE 25 MIDDLE EAST & AFRICA HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 26 MIDDLE EAST & AFRICA CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 27 MIDDLE EAST & AFRICA ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 28 MIDDLE EAST & AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 29 MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 30 MIDDLE EAST & AFRICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 31 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 94
TABLE 32 MIDDLE EAST & AFRICA DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 33 MIDDLE EAST & AFRICA ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 34 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 35 MIDDLE EAST & AFRICA OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 36 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 104
TABLE 37 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 104
TABLE 38 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 39 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 105
TABLE 40 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 105
TABLE 41 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 105
TABLE 42 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 106
TABLE 43 MIDDLE EAST AND AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 106
TABLE 44 MIDDLE EAST AND AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 45 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 106
TABLE 46 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 106
TABLE 47 MIDDLE EAST AND AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 107
TABLE 48 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
TABLE 49 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 107
TABLE 50 MIDDLE EAST AND AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 107
TABLE 51 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 107
TABLE 52 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 108
TABLE 53 MIDDLE EAST AND AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 108
TABLE 54 MIDDLE EAST AND AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 108
TABLE 55 MIDDLE EAST AND AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 108
TABLE 56 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 108
TABLE 57 MIDDLE EAST AND AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 108
TABLE 58 MIDDLE EAST AND AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 109
TABLE 59 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 60 MIDDLE EAST AND AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 61 MIDDLE EAST AND AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 109
TABLE 62 MIDDLE EAST AND AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 63 MIDDLE EAST AND AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 110
TABLE 64 MIDDLE EAST AND AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
TABLE 65 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 110
TABLE 66 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 111
TABLE 67 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 68 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 69 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 112
TABLE 70 SOUTH AFRICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 112
TABLE 71 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 72 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 113
TABLE 73 SOUTH AFRICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 113
TABLE 74 SOUTH AFRICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 75 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 76 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 77 SOUTH AFRICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 78 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 79 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 114
TABLE 80 SOUTH AFRICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 114
TABLE 81 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
TABLE 82 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 83 SOUTH AFRICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 84 SOUTH AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 115
TABLE 85 SOUTH AFRICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 115
TABLE 86 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 87 SOUTH AFRICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 88 SOUTH AFRICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 89 SOUTH AFRICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 90 SOUTH AFRICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
TABLE 91 SOUTH AFRICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 92 SOUTH AFRICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 93 SOUTH AFRICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 117
TABLE 94 SOUTH AFRICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 117
TABLE 95 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 118
TABLE 96 SOUTH AFRICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 118
TABLE 97 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 98 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 99 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 119
TABLE 100 SAUDI ARABIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 101 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 102 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 120
TABLE 103 SAUDI ARABIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 120
TABLE 104 SAUDI ARABIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 105 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 106 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 107 SAUDI ARABIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 121
TABLE 108 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 109 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 121
TABLE 110 SAUDI ARABIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 111 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 122
TABLE 112 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 113 SAUDI ARABIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 114 SAUDI ARABIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 122
TABLE 115 SAUDI ARABIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 122
TABLE 116 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 117 SAUDI ARABIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 118 SAUDI ARABIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
TABLE 119 SAUDI ARABIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
TABLE 120 SAUDI ARABIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 121 SAUDI ARABIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 122 SAUDI ARABIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 123 SAUDI ARABIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 124
TABLE 124 SAUDI ARABIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 125 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 125
TABLE 126 SAUDI ARABIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 125
TABLE 127 UAE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 128 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 129 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 126
TABLE 130 UAE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 126